Moderate-intensity statin plus ezetimibe
Intervention1 paper4 findings
Outcomes
3Revascularization
no changein humans1RR 0.96Low certainty
1 study
Revascularization
no changein humans1RR 0.96Low certainty
Moderate-intensity statin plus ezetimibe has no effect on revascularization in humans (RR 0.96, 95% CI 0.83-1.12).
Human trialafter percutaneous coronary intervention
Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis · Journal of clinical lipidology · 4 Aug 2026
Major adverse cardiovascular events
no changein humans1RR 0.99Low certainty
1 study
Major adverse cardiovascular events
no changein humans1RR 0.99Low certainty
Moderate-intensity statin plus ezetimibe has no effect on major adverse cardiovascular events in humans (RR 0.99, 95% CI 0.65-1.52).
Human trialafter percutaneous coronary intervention
Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis · Journal of clinical lipidology · 4 Aug 2026
Mortality
downin humans1RR 0.89Low certainty
1 study
Mortality
downin humans1RR 0.89Low certainty
Moderate-intensity statin plus ezetimibe decreases mortality in humans (RR 0.89, 95% CI 0.84-0.95).
Human trialafter percutaneous coronary intervention
Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis · Journal of clinical lipidology · 4 Aug 2026
Associations
1Type 2 diabetes
downin humans1RR 0.83Low certainty
1 study
Type 2 diabetes
downin humans1RR 0.83Low certainty
Moderate-intensity statin plus ezetimibe lowers the risk of type 2 diabetes in humans (RR 0.83, 95% CI 0.76-0.91).
Human trialafter percutaneous coronary intervention
Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis · Journal of clinical lipidology · 4 Aug 2026